Regulation of T cell function by microRNA-720

Area of Science:

• Immunology
• Virology
• Molecular Biology

Background:

• Chronic hepatitis B virus (HBV) infection poses a significant global health challenge.
• Impaired cytotoxic T lymphocyte (CTL) activity, due to exhaustion and reduction, limits the immune response against HBV.
• Understanding T cell responses in lymphoid organs of chronic HBV infection (CHBI) patients is crucial but limited.

Purpose of the Study:

• To investigate the characteristics of HBV-specific CD8(+) T cell responses in lymphoid organs of CHBI patients.
• To explore the role of microRNA-720 (miR-720) in regulating T cell function during chronic HBV infection.

Main Methods:

• Comparative analysis of HBV-specific CD8(+) T cells in spleen, peripheral blood, and liver of CHBI patients.
• T cell stimulation assays to assess proliferation and cytokine production (IFNγ).
• Quantitative analysis of miR-720 expression and functional studies using primary human CD8(+) T cells.
• Assessment of transforming growth factor-beta (TGFβ) involvement and its correlation with treatment outcomes.

Main Results:

• HBV-specific CD8(+) T cells were more abundant in the spleen compared to peripheral blood and liver.
• Despite responding to TCR stimulation and producing IFNγ, these splenic T cells exhibited poor proliferation.
• miR-720 expression was upregulated in HBV-specific CD8(+) T cells from CHBI patients.
• Overexpression of miR-720 inhibited T cell proliferation, and TGFβ sustained miR-720 upregulation.
• Blood TGFβ levels correlated with the efficacy of type I interferon treatment in CHBI patients.

Conclusions:

• HBV-specific CD8(+) T cells in the spleen of CHBI patients display functional impairment characterized by poor proliferation, linked to elevated miR-720 levels.
• TGFβ plays a role in sustaining miR-720 upregulation, potentially contributing to T cell dysfunction.
• Therapeutic strategies targeting miR-720 present a potential avenue for restoring anti-HBV immunity in CHBI patients.